Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2
暂无分享,去创建一个
[1] Patrick Royston,et al. A new measure of prognostic separation in survival data , 2004, Statistics in medicine.
[2] Elena B. Elkin,et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers , 2008, BMC Medical Informatics Decis. Mak..
[3] J. Robson,et al. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease , 2007, Heart.
[4] N. Cook,et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.
[5] Tx Station. Stata Statistical Software: Release 7. , 2001 .
[6] N. Paynter,et al. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men , 2008, Circulation.
[7] J. Hippisley-Cox,et al. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study , 2007, Heart.
[8] D G Altman,et al. Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines , 2004, British Journal of Cancer.
[9] E. Elkin,et al. Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[10] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[11] Patrick Royston,et al. Explained Variation for Survival Models , 2006 .
[12] Gary S Collins,et al. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study , 2010, BMJ : British Medical Journal.
[13] K. Anderson,et al. Cardiovascular disease risk profiles. , 1991, American heart journal.
[14] Y. Vergouwe,et al. Validation, updating and impact of clinical prediction rules: a review. , 2008, Journal of clinical epidemiology.
[15] F. Harrell,et al. Evaluating the yield of medical tests. , 1982, JAMA.
[16] J. Hippisley-Cox,et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study , 2007, BMJ : British Medical Journal.
[17] N. Obuchowski,et al. Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.
[18] P. Royston,et al. Prognosis and prognostic research: application and impact of prognostic models in clinical practice , 2009, BMJ : British Medical Journal.
[19] H. Young. Putting prevention first - vascular checks: risk assessment and management , 2010 .
[20] J. Hippisley-Cox,et al. Advantages of QRISK2 (2010): the key issue is ethnicity and extent of reallocation , 2011, Heart.
[21] A. Sheikh,et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 , 2008, BMJ : British Medical Journal.
[22] Gary S Collins,et al. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study , 2009, BMJ : British Medical Journal.
[23] Yvonne Vergouwe,et al. Development and validation of a prediction model with missing predictor data: a practical approach. , 2010, Journal of clinical epidemiology.